ADC Therapeutics Director Azelby Sells Shares Amid Price Target Cut

ADC Therapeutics Director Azelby Sells Shares Worth Over $20,000

Robert Azelby, a director at ADC Therapeutics SA (NYSE:ADCT), sold some of his company shares on June 17, 2024. This sale was done to handle tax requirements related to the vesting of restricted share units. In total, he sold 6,995 common shares at $2.89 each, making the total value over $20,215.